103 related articles for article (PubMed ID: 23454530)
1. Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.
Nofal ZM; Srour AM; El-Eraky WI; Saleh DO; Girgis AS
Eur J Med Chem; 2013 May; 63():14-21. PubMed ID: 23454530
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis and 2D-QSAR study of novel vasorelaxant active benzofuran-pyridine hybrids.
Srour AM; Abd El-Karim SS; Saleh DO; El-Eraky WI; Nofal ZM
Bioorg Med Chem Lett; 2016 May; 26(10):2557-2561. PubMed ID: 27048942
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and vasodilation activity of some novel bis(3-pyridinecarbonitrile) derivatives.
Barsoum FF
Eur J Med Chem; 2010 Nov; 45(11):5176-82. PubMed ID: 20828883
[TBL] [Abstract][Full Text] [Related]
4. Facile synthesis, vasorelaxant properties and molecular modeling studies of 2-amino-8a-methoxy-4H-pyrano[3,2-c]pyridine-3-carbonitriles.
Girgis AS; Ismail NS; Farag H
Eur J Med Chem; 2011 Jun; 46(6):2397-407. PubMed ID: 21489662
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new 3-pyridinecarboxylates of potential vasodilation properties.
Girgis AS; Mishriky N; Farag AM; El-Eraky WI; Farag H
Eur J Med Chem; 2008 Sep; 43(9):1818-27. PubMed ID: 18241958
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
7. Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
Dong X; Liu Y; Yan J; Jiang C; Chen J; Liu T; Hu Y
Bioorg Med Chem; 2008 Sep; 16(17):8151-60. PubMed ID: 18678502
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and vasodilative activity of tanshinone IIA derivatives.
Bi YF; Wang ZJ; Guan RF; Ye YT; Chen YY; Zhang YB; Liu HM
Bioorg Med Chem Lett; 2012 Aug; 22(15):5141-3. PubMed ID: 22765898
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
Dong X; Chen J; Jiang C; Liu T; Hu Y
Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
11. Regioselective synthesis and molecular modeling study of vasorelaxant active 7,9-dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10-diones.
Girgis AS; Ismail NS; Farag H; el-Eraky WI; Saleh DO; Tala SR; Katritzky AR
Eur J Med Chem; 2010 Sep; 45(9):4229-38. PubMed ID: 20615586
[TBL] [Abstract][Full Text] [Related]
12. Benzofuran-morpholinomethyl-pyrazoline hybrids as a new class of vasorelaxant agents: synthesis and quantitative structure-activity relationship study.
Hassan GS; Rahman DE; Abdel Saleh DO; Abdel Jaleel GA
Chem Pharm Bull (Tokyo); 2014; 62(12):1238-51. PubMed ID: 25450632
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators.
Khalifa NM; Srour AM; Abd El-Karim SS; Saleh DO; Al-Omar MA
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072621
[TBL] [Abstract][Full Text] [Related]
14. Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings: design and synthesis of 5-nitro derivatives.
Estrada-Soto S; Villalobos-Molina R; Aguirre-Crespo F; Vergara-Galicia J; Moreno-Díaz H; Torres-Piedra M; Navarrete-Vázquez G
Life Sci; 2006 Jun; 79(5):430-5. PubMed ID: 16487544
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and vasorelaxant evaluation of novel coumarin-pyrimidine hybrids.
Amin KM; Awadalla FM; Eissa AA; Abou-Seri SM; Hassan GS
Bioorg Med Chem; 2011 Oct; 19(20):6087-97. PubMed ID: 21908192
[TBL] [Abstract][Full Text] [Related]
16. Vasodilatory activity and antihypertensive profile mediated by inhibition of phosphodiesterase type 1 induced by a novel sulfonamide compound.
Pontes LB; Antunes F; Sudo RT; Raimundo JM; Lima LM; Barreiro EJ; Zapata-Sudo G
Fundam Clin Pharmacol; 2012 Dec; 26(6):690-700. PubMed ID: 22066694
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and exploration of QSAR model of 2-methyl-3-[2-(2-methylprop-1-en-1-yl)-1H-benzimidazol-1-yl]pyrimido[1,2-a]benzimidazol-4(3H)-one as potential antibacterial agents.
Sharma P; Kumar A; Sharma M; Singh J; Bandyopadhyay P; Sathe M; Kaushik MP
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):294-301. PubMed ID: 21699375
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxant effects of Acer nikoense extract and isolated coumarinolignans on rat aortic rings.
Iizuka T; Nagumo S; Yotsumoto H; Moriyama H; Nagai M
Biol Pharm Bull; 2007 Jun; 30(6):1164-6. PubMed ID: 17541175
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel vasodilatory active nicotinate esters with amino acid function.
Girgis AS; Kalmouch A; Ellithey M
Bioorg Med Chem; 2006 Dec; 14(24):8488-94. PubMed ID: 16973365
[TBL] [Abstract][Full Text] [Related]
20. Novel synthesis of [1]-benzothiepino[5,4-b]pyridine-3-carbonitriles and their anti-inflammatory properties.
Girgis AS; Mishriky N; Ellithey M; Hosni HM; Farag H
Bioorg Med Chem; 2007 Mar; 15(6):2403-13. PubMed ID: 17267228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
